In one such previous study, Menard et al. reported that a high number of infiltrating CD8+ lymphocytes in breast cancer was associated with better prognosis in patients younger than 40 years old but not in those older than 40 years old [30]. This evidence concerns the gene CD8A and breast carcinoma.